期刊文献+

一种测定MDR肿瘤细胞内外阿霉素浓度的方法 被引量:7

An Approach to Determination of the Intracellular and Extracellular Concentrations of Doxorubicin for MDR Cancer Cells
下载PDF
导出
摘要 研究提出K5 62 /A细胞内外阿霉素浓度的反相高效液相色谱 -荧光测定法 .细胞内阿霉素浓度测定采用LichrospherC18色谱柱 ,甲醇 0 0 1%醋酸 ( 5 0∶5 0 ,V/V)流动相 ,流速 1 0mL/min ,柱温 3 5℃ ;细胞外阿霉素浓度测定采用LichrospherC18色谱柱 ,甲醇 0 0 1%醋酸 ( 5 5∶45 ,V/V)流动相 ,流速 0 8mL/min ,柱温 3 5℃ .荧光检测器波长λex=495nm ,λem=5 60nm ,均以盐酸柔红霉素为内标 .研究结果表明 ,该方法简单、准确、线性范围宽、检测限低 ,精确度和回收率良好 ,可用于多药耐药肿瘤细胞内外阿霉素浓度的动态变化规律研究 . A method using RP-HPLC with fluorescence detector was developed for deter-mining the intracellular and extracellular concentrations of Doxorubicin (Dox) in K562/A cells. To analyze the intracellular concentration of Dox, a Lichrospher C-18 column maintained at 35 degreesC was used, and the mobile phase consisted of methanol-0.01% acetic acid solution (50: 50, V/V) at the flow rate of 1.0 mL/min. A Lichrospher C-18 column maintained at 35 degreesC was used to analyze the extracellular concentration of Dox, and the mobile phase consisted of Methanol-0.01% acetic acid solution (55:45, V/V) at the flow rate of 0.8 mL/min. Daunorubicin was used as the internal standard, and the excitation wavelength and emission wavelength were 495 nm and 560 nm respectively. The proposed method has been verified to be simple, accurate and sensitive. It has low limit of determination, wide linear range, satisfied precision, and good mean recovery. For multi-drug resistance cancer cells, the dynamic status of the intracellular and extracellular concentrations of Dox could be investigated by using this method.
出处 《化学学报》 SCIE CAS CSCD 北大核心 2004年第12期1162-1165,MJ05,共5页 Acta Chimica Sinica
基金 浙江省中医药科研计划 (No.2 0 0 3C0 76)资助项目
关键词 液相色谱分析 阿霉素 多药耐药机制 肿瘤细胞 K562/A细胞 化疗 抗癌药物 HPLC doxorubicin MDR cancer cell K562/A cell
  • 相关文献

参考文献7

  • 1[1]van Bambeke, F.; Balzi, E.; Tulkens, P. M. Biochem. Pharmacol. 2000, 60(4), 457.
  • 2[2]Lautier, D.; Canitrot, Y.; Deeley, R. G.; Cole-Susan, P. C. Biochem. Pharmacol. 1996, 52(7), 967.
  • 3[3]Marbeuf-Gueye, C.; Salern, M.; Quidu, P.; Garnier-Suillerot, A. Eur. J. Pharmacol. 2000, 391, 207.
  • 4[4]Praet, M.; Stryckmans, P.;Ruysschaert, J. M. Biochem. Pharmacol. 1996, 51, 1341.
  • 5[5]Ford, J. M.; Bruggemann, E. P.; Pastan, I.; Gottesman, M. M.; Hait, W. H. Cancer Res. 1990, 50, 1748.
  • 6[6]Dufer, J. Anal. Cell. Pathol. 1996, 10(2), 192.
  • 7[8]Lee, H. J.; Ahn, B.-N.; Yoon, E. J.; Paik, W. H.; Shim, C. K.; Lee, M. G. Int. J. Pharm. 1995, 121(1), 1.

同被引文献62

引证文献7

二级引证文献16

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部